For most of human history, the brain has been the final hardware. You inherited it. You trained it. You worked within its limits. The idea that those limits were negotiable — that the nervous system could be extended, augmented, or interfaced with external intelligence — was science fiction.
It is no longer fiction. Neuralink has implanted devices in three human patients. China has launched a national BCI roadmap. The FDA has issued Breakthrough Device status for neural interface applications. The frontier has moved. The question is no longer whether neural extension is possible. It is which brands will define it.
NeurExtend.com is positioned at exactly this moment. It does not describe a specific technology or a single product. It describes the direction of an entire field: extending what neural systems — biological and artificial — can accomplish. Every company in this space is building toward the same goal. Only one domain names it this precisely.
They are starting points.
The acquirer of NeurExtend.com does not inherit a clever combination of syllables. They inherit a statement of intent — a brand that tells every user, investor, and partner exactly what the company believes about the future of human capability, before a single product specification is ever written.